SK bioscience, the biopharmaceutical arm of South Korea's SK Group, said on Wednesday it has achieved a "final victory" in a ...

South Korean vaccine developer SK bioscience has won a final ruling in a patent dispute with Moderna (Nasdaq: MRNA) over key ...

SEOUL, April 23 (Yonhap) -- SK bioscience Co., the biopharmaceutical arm of South Korea's SK Group, said Wednesday it has ...

Considering that PD-1/L1 are some of the most lucrative drug treatments across the industry, this could be a major coup for any mRNA developer that manages to successfully co-develop such a treatment.

They could also offer a more potent option to conventional flu shots, according to mRNA vaccine developers. Current flu vaccines generally offer only around 40% to 60% protective efficacy ...

The company recently secured approval for olezarsen in FCS, and looks odds on for a follow-up approval in SHTG. Click here to ...

Donald Trump and Elon Musk are making corruption and graft the main business of the US government. They have fired all the ...

You can catch Opening Bid on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. There isn’t much Pat ...

FORT LAUDERDALE, FL / ACCESS Newswire / April 21, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including ...

Analytical laboratory testing plays a pivotal role in every stage of drug development and manufacturing. From route design and optimization to clinical trials and ultimately the finished product, ...

HHS SECRETARY ROBERT F. KENNEDY JR.: People get measles because they don’t vaccinate. They get measles because the vaccine wanes. The vaccines wane about 4.8% per year. And so, you know, that — it’s a ...